Strong Funding Base With an annual revenue ranging from $50 million to $100 million, the Ovarian Cancer Research Alliance (OCRA) represents a substantial funding organization within the non-profit sector. This financial strength indicates potential for partnerships in sponsored research, technology solutions, and collaborative campaigns.

Research Leadership As the leading private funder of ovarian and gynecologic cancer research, OCRA is actively investing in innovative projects. Businesses offering cutting-edge research tools, data analysis platforms, or biotech solutions can explore strategic relationships to support or enhance OCRA's research initiatives.

Policy Expansion OCRA recently launched the Center for Public Policy and continues to advocate at the national level. Organizations specializing in advocacy platforms, lobbying tools, or policy engagement technology could find opportunities to provide solutions that amplify their influence and operational efficiency.

Community Engagement OCRA offers patient support programs including survivor pairing and educational conferences, indicating a commitment to community and patient engagement. Companies providing digital health solutions, patient outreach platforms, or event management services may find opportunities to collaborate on patient-centered initiatives.

Strategic Partnerships Recent collaborations with organizations like the Rivkin Center and Iris by OncoHealth demonstrate OCRA’s interest in forming strategic alliances to expand education, research, and supportive care. Businesses offering supportive care technology, educational resources, or partnership facilitation can explore mutually beneficial engagement opportunities.